These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2718607)

  • 21. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus.
    Barrett T; Belsham GJ; Subbarao SM; Evans SA
    Virology; 1989 May; 170(1):11-8. PubMed ID: 2718375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.
    Legrand FA; Verardi PH; Jones LA; Chan KS; Peng Y; Yilma TD
    J Virol; 2004 Mar; 78(6):2770-9. PubMed ID: 14990697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of vaccinia promoters by heterologous expression of hepatitis B surface antigen in mouse cells infected by recombinant vaccinia viruses.
    Barbeyron T; Mars M; Schroeder E; Malpièce Y; Plucienniczak A; Beaud G; Streeck RE
    Biochim Biophys Acta; 1987 Dec; 910(3):240-4. PubMed ID: 3676323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant vaccinia virus expressing hepatitis B virus middle surface protein. Restricted expression of HBV antigens in human diploid cells.
    Kutinová L; Nĕmecková S; Hamsíková E; Press M; Závadová H; Hirsch I; Nĕmecek V; Krchnák V; Smrt J; Slonim D
    Arch Virol; 1990; 112(3-4):181-93. PubMed ID: 2378567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.
    Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD
    Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new genetically engineered vaccine for animal growth promotion.
    Xu WZ; Du NX; Li GD; Wang Y; Li ZP
    Sci China B; 1994 Oct; 37(10):1234-41. PubMed ID: 7865123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Construction of recombinant vaccinia virus expressing HSV-2 gD gene as live recombinant vaccine strain].
    Yan H; Rong M; Ruan L; Hou Y; He N; Zhu J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Mar; 11(1):16-20. PubMed ID: 15619895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
    NAM JH; BANG HS; CHO HW; CHUNG YH
    Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vaccination with three HIV-1 cross neutralizing epitopes fused to HBV S antigen could induce robust antibody immune response in mice].
    Li XR; Chen H; Wang W; Deng Y; Qi XR; Gao YY; Meng X; Tan WJ; Ruan L
    Bing Du Xue Bao; 2008 Jul; 24(4):260-7. PubMed ID: 18780627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of antibody formation to the vaccinia virus in human subjects and rabbits in response to the administration of a recombinant vaccinia-hepatitis B vaccine].
    Cheliapov NV; Chernos VI; Andzhaparidze OG
    Vopr Virusol; 1988; 33(2):175-9. PubMed ID: 2842961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of recombinant vaccinia virus expressing Rinderpest Virus nucleocapsid protein and its immunogenicity in mice.
    Ohishi K; Kamata H; Ohkubo S; Yamanouchi K; Kai C
    J Vet Med Sci; 1998 May; 60(5):655-6. PubMed ID: 9637306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.
    Shida H; Hinuma Y; Hatanaka M; Morita M; Kidokoro M; Suzuki K; Maruyama T; Takahashi-Nishimaki F; Sugimoto M; Kitamura R
    J Virol; 1988 Dec; 62(12):4474-80. PubMed ID: 3184271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinia virus recombinants co-expressing hepatitis B virus surface and core antigens.
    Kunke D; Broucek J; Kutinová L; Nĕmecková S; Ludvíková V; Strnad I; Kramosil J; Nemcová J; Schramlová J; Simonová V
    Virology; 1993 Jul; 195(1):132-9. PubMed ID: 8317089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
    Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG
    J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity.
    Karayiannis P; O'Rourke S; McGarvey MJ; Luther S; Waters J; Goldin R; Thomas HC
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2167-72. PubMed ID: 1654376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live recombinant vaccines using genetically engineered vaccinia virus.
    Paoletti E; Perkus ME; Piccini A
    Antiviral Res; 1985; Suppl 1():301-7. PubMed ID: 3866514
    [No Abstract]   [Full Text] [Related]  

  • 38. Two vaccinia virus recombinants expressing HBsAg with different concentration of A- and pre-S2 antigenic determinants.
    Chelyapov NV; Rakhilina LE; Antonova TP; Chernos VI; Grigorjev VG; Chudakova EA; Pashvykina GV; Zakharova LG; Altstein AD; Kutinová L
    Acta Virol; 1991 Sep; 35(5):413-22. PubMed ID: 1726675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral immune response elicited by highly attenuated variants of vaccinia virus and by an attenuated recombinant expressing HIV-1 envelope protein.
    Dallo S; Maa JS; Rodriguez JR; Rodriguez D; Esteban M
    Virology; 1989 Nov; 173(1):323-9. PubMed ID: 2510402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences.
    Smith KA; Stallard V; Roos JM; Hart C; Cormier N; Cohen LK; Roberts BE; Payne LG
    Vaccine; 1993; 11(1):43-53. PubMed ID: 8427036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.